Silencing of the hPOT1 gene by RNA inference promotes apoptosis and inhibits proliferation and aggressive phenotype of gastric cancer cells, likely through up-regulating PinX1 expression

Journal of Clinical Pathology

Volumn 64, Issue 12, 2011, Pages 1051-1057

  Wan, Shun Mei ^a   Tie, Jun ^a   Zhang, Ya Fei ^a   Guo, Jun ^a   Yang, Liu Qin ^a   Wang, Jun ^a   Xia, Shi Hai ^a   Yang, Shi Ming ^a   Wang, Rong Quan ^a   Fang, Dian Chun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN; PROTEIN PINX1; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; CELL PROLIFERATION; GENE; GENE EXPRESSION; GENE SILENCING; HPOT1 GENE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; OPTICAL DENSITY; PHENOTYPE; PRIORITY JOURNAL; STOMACH CANCER; STOMACH MUCOSA;

ADULT; AGED; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GASTRIC MUCOSA; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHENOTYPE; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TELOMERASE; TELOMERE-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 81855170095     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200211     Document Type: Article

References (34)

1. Wu CW, Lui WY. Current management of gastric cancer in Taiwan. Asian J Surg 2001;48:253-7.
2. Thompson GB, van Heerden JA, Sarr MG. Adenocarcinoma of the stomach: are we making progress? Lancet 1993;342:713-18.
3. Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science 2002;297:565-9. (Pubitemid 34815334)
4. Feldser DM, Hackett JA, Greider CW. Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer 2003;3:623-7. (Pubitemid 37328834)
5. Kim SH, Kaminker P, Campisi J. TIN2, a new regulator of telomere length in human cells. Nat Genet 1999;23:405-12.
6. Stansel RM, de Lange T, Griffith JD. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J 2001;20:5532-40. (Pubitemid 32959473)
7. Anno K, Hayashi A, Takahashi T, et al. Telomerase activation induces elongation of the telomeric single-strand overhang, but does not prevent chromosome aberrations in human vascular endothelial cells. Biochem Biophys Res Commun 2007;353:926-32. (Pubitemid 46084964)
8. Baumann P, Cech TR. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 2001;292:1171-5. (Pubitemid 32440940)
9. Colgin LM, Baran K, Baumann P, et al. Human POT1 facilitates telomere elongation by telomerase. Curr Biol 2003;13:942-6. (Pubitemid 36632143)
10. Loayza D, De Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003;423:1013-18. (Pubitemid 36806919)
11. Blackburn EH. Switching and signaling at the telomere. Cell 2001;106:661-73. (Pubitemid 32900658)
12. Barrientos KS, Kendellen MF, Freibaum BD, et al. Distinct functions of POT1 at telomeres. Mol Cell Biol 2008;28:5251-64.
13. He H, Wang Y, Guo X, et al. Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosis congenita. Mol Cell Biol 2009;29:229-40.
14. Possemato R, Timmons JC, Bauerlein EL, et al. Suppression of hPOT1 in diploid human cells results in an hTERT-dependent alteration of telomere length dynamics. Mol Cancer Res 2008;6:1582-93.
15. Kondo T, Oue N, Yoshida K, et al. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma. Cancer Res 2004;64:523-9. (Pubitemid 38120891)
16. Fujii K, Sasahira T, Moriwaka Y, et al. Protection of telomeres 1 protein levels are associated with telomere length in gastric cancer. Int J Mol Med 2008;21:599-604.
17. Ning X, Yang S, Wang R, et al. POT1 deficiency alters telomere length and telomere-associated gene expression in human gastric cancer cells. Eur J Cancer Prev 2010;19:345-51.
18. Yu ST, Chen L, Wang HJ, et al. hTERT promotes the invasion of telomerase-negative tumor cells in vitro. Int J Oncol 2009;35:329-36.
19. Zhou XZ, Lu KP, Zhou XZ, et al. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 2001;107:347-59. (Pubitemid 33049978)
20. Zhang B, Bai YX, Ma HH, et al. Silencing PinX1 compromises telomere length maintenance as well as tumorigenicity in telomerase-positive human cancer cells. Cancer Res 2009;69:75-83.
21. Wang HB, Wang XW, Zhou G, et al. PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway. J Gastrointest Surg 2010;14:1227-34.
22. Banik SS, Counter CM. Characterization of interactions between PinX1 and human telomerase subunits hTERT and hTR. J Biol Chem 2004;279:51745-8. (Pubitemid 39656540)
23. Cai MY, Zhang B, He WP, et al. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma. Cancer Sci 2010;101:1543-9.
24. Sobin LH, Wittekin C. UICC TNM Classification of Malignant Tumors. 5th edn. New York, Wiley 1997.
25. Pan GD, Yang JQ, Yan LN, et al. Reversal of multi-drug resistance by pSUPER-shRNA- mdr1 in vivo and in vitro. World J Gastroenterol 2009;15:431-40.
26. Hockemeyer D, Sfeir AJ, Shay JW, et al. POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J 2005;24:2667-78. (Pubitemid 41076322)
27. Veldman T, Etheridge KT, Counter CM. Loss of hPot1 function leads to telomere instability and a cut-like phenotype. Curr Biol 2004;14:2264-70. (Pubitemid 40033364)
28. Lin SY, Elledge SJ. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 2003;113:881-97.
29. Yang SM, Fang DC, Luo YH, et al. Alterations of telomerase activity and terminal restriction fragment in gastric cancer and its premalignant lesions. J Gastroenterol Hepatol 2001;16:876-82.
30. Fang DC, Yang SM, Zhou XD, et al. Telomere erosion is independent of microsatellite instability but related to loss of heterozygosity in gastric cancer. World J Gastroenterol 2001;7:522-6.
31. Engelhardt M, Drullinsky P, Guillem J, et al. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997;3:1931-41. (Pubitemid 27505118)
32. Oh BK, Jo Chae K, Park C, et al. Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis. J Hepatol 2003; 39:786-92. (Pubitemid 37372189)
33. Lin X, Gu J, Lu C, et al. Expression of telomere-associated genes as prognostic markers for overall survival in patients with non-small cell lung cancer. Clin Cancer Res 2006;12:5720-5. (Pubitemid 44629601)
34. Hahn WC, Weinberg RA. Rules for making human tumor cells. N Engl J Med 2002;347:1593-603. (Pubitemid 35315841)